HOSPITALIZATIONS AMONG PATIENTS WITH BOTH COLORECTAL CANCER AND TYPE II DIABETES MELLITUS TREATED WITH METFORMIN VS. SULFONYLUREAS: A SEER-MEDICARE ANALYSIS

被引：0
|
作者：
Rane, A. [1 ]
Reddy, S. [2 ]
Kaliki, S. [2 ]
Kaler, N. [2 ]
Dungrani, R. K. [2 ]
Patel, N. [2 ]
Murimi, I. B. [2 ]
机构：
[1] Agios Pharmaceut, Cambridge, MA USA
[2] MCPHS Univ, Boston, MA USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
RWD116
引用
收藏
页码：S383 / S383
页数：1
相关论文
共 50 条
  • [31] Temporal and Geographic Variation of Intensity Modulated Radiation Therapy (IMRT) Utilization in Patients With Colorectal Cancer: A SEER-Medicare Based Analysis
    Sio, T. T.
    Shah, N. D.
    Swanson, K. M.
    Inselman, J. W.
    Ashman, J. B.
    Kreofsky, C. R.
    Chang, K.
    Buchholtz, L. M.
    Baker, M. B.
    Miller, R. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S580 - S581
  • [32] How does autoimmune disease impact treatment and outcomes among patients with lung cancer? A national SEER-Medicare analysis
    Khan, Saad A.
    Pruitt, Sandi L.
    Xuan, Lei
    Makris, Una
    Gerber, David E.
    LUNG CANCER, 2018, 115 : 97 - 102
  • [33] Frequency of Unplanned Surgery in Patients with Stage IV Colorectal Cancer Receiving Palliative Chemotherapy with an Intact Primary: An Analysis of SEER-Medicare
    Lorimer, P. D.
    Motz, B. M.
    Kirks, R. C.
    Han, Y.
    Hwang, J. J.
    Salo, J. C.
    Hill, J. S.
    ANNALS OF SURGICAL ONCOLOGY, 2018, 25 : S36 - S36
  • [34] Frequency of unplanned surgery in patients with stage IV colorectal cancer receiving palliative chemotherapy with an intact primary: An analysis of SEER-Medicare
    Lorimer, Patrick D.
    Motz, Benjamin M.
    Kirks, Russell C.
    Han, Yimei
    Symanowski, James T.
    Hwang, Jimmy J.
    Salo, Jonathan C.
    Hill, Joshua S.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (03) : 407 - 414
  • [35] Role of pre-existing type 2 diabetes in colorectal cancer survival among older Americans: a SEER-Medicare population-based study 2002-2011
    El Brahimi, Sanae
    Smith, Matthew Lee
    Pinheiro, Paulo S.
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2019, 34 (08) : 1467 - 1475
  • [36] Impact of metformin on survival in patients with type II diabetes and metastatic colorectal cancer.
    He, Wen-zhuo
    Xia, Liang-ping
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [37] Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
    C R Garrett
    H M Hassabo
    N A Bhadkamkar
    S Wen
    V Baladandayuthapani
    B K Kee
    C Eng
    M M Hassan
    British Journal of Cancer, 2012, 106 : 1374 - 1378
  • [38] Incidence of colon cancer among patients with type II diabetes mellitus
    Pata, C
    Yazar, A
    Konca, K
    Hafta, A
    DIABETOLOGIA, 2001, 44 : A225 - A225
  • [39] Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
    Garrett, C. R.
    Hassabo, H. M.
    Bhadkamkar, N. A.
    Wen, S.
    Baladandayuthapani, V.
    Kee, B. K.
    Eng, C.
    Hassan, M. M.
    BRITISH JOURNAL OF CANCER, 2012, 106 (08) : 1374 - 1378
  • [40] The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
    Tian Shan
    Lei Hong-Bo
    Liu Yu-Lan
    Chen Yan
    Dong Wei-Guo
    慢性疾病与转化医学（英文）, 2017, 3 (03) : 169 - 175
12345